Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Rao

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Scientific Reports|February 6, 2019
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin LymphomaSarah A Milgrom, Hesham Elhalawani, Joonsang Lee, et al.
Clinical and Translational Radiation Oncology|July 1, 2021
<sup>18</sup>FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancerHesham Elhalawani, Carlos E Cardenas, Stefania Volpe, et al.
Journal of Cardiovascular Imaging|October 16, 2019
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation TherapySarah A Milgrom, Bibin Varghese, Gregory W Gladish, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Communications|June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myelomaJosh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Iscience|July 24, 2025
Primary and metastatic cellular landscapes in human pancreatic cancerNina G Steele, Veerin R Sirihorachai, Ahmed M Elhossiny, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
JCO Precision Oncology|March 16, 2022
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic ChemotherapyHiroko Masuda, Kenichi Harano, Sakiko Miura, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Scientific Reports|February 6, 2019
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin LymphomaSarah A Milgrom, Hesham Elhalawani, Joonsang Lee, et al.
Clinical and Translational Radiation Oncology|July 1, 2021
<sup>18</sup>FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancerHesham Elhalawani, Carlos E Cardenas, Stefania Volpe, et al.
Journal of Cardiovascular Imaging|October 16, 2019
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation TherapySarah A Milgrom, Bibin Varghese, Gregory W Gladish, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Communications|June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myelomaJosh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Iscience|July 24, 2025
Primary and metastatic cellular landscapes in human pancreatic cancerNina G Steele, Veerin R Sirihorachai, Ahmed M Elhossiny, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
JCO Precision Oncology|March 16, 2022
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic ChemotherapyHiroko Masuda, Kenichi Harano, Sakiko Miura, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Pageof 22